Japan To Start Clinical Study On Lilly's Gemzar For Ovarian Cancer
This article was originally published in PharmAsia News
Executive Summary
Minister of Health, Labor and Welfare Akira Nagatsuma said the ministry is working with Eli Lilly to start a clinical study on Gemzar (gemcitabine) for ovarian cancer from April